全文获取类型
收费全文 | 9885篇 |
免费 | 940篇 |
国内免费 | 1289篇 |
专业分类
12114篇 |
出版年
2024年 | 55篇 |
2023年 | 218篇 |
2022年 | 470篇 |
2021年 | 705篇 |
2020年 | 527篇 |
2019年 | 561篇 |
2018年 | 525篇 |
2017年 | 398篇 |
2016年 | 542篇 |
2015年 | 691篇 |
2014年 | 871篇 |
2013年 | 844篇 |
2012年 | 1002篇 |
2011年 | 866篇 |
2010年 | 477篇 |
2009年 | 475篇 |
2008年 | 501篇 |
2007年 | 440篇 |
2006年 | 331篇 |
2005年 | 286篇 |
2004年 | 252篇 |
2003年 | 167篇 |
2002年 | 177篇 |
2001年 | 81篇 |
2000年 | 88篇 |
1999年 | 76篇 |
1998年 | 54篇 |
1997年 | 53篇 |
1996年 | 36篇 |
1995年 | 42篇 |
1994年 | 41篇 |
1993年 | 23篇 |
1992年 | 29篇 |
1991年 | 31篇 |
1990年 | 31篇 |
1989年 | 33篇 |
1988年 | 14篇 |
1987年 | 19篇 |
1986年 | 11篇 |
1985年 | 11篇 |
1984年 | 3篇 |
1983年 | 11篇 |
1982年 | 10篇 |
1981年 | 5篇 |
1979年 | 3篇 |
1977年 | 5篇 |
1973年 | 3篇 |
1962年 | 2篇 |
1950年 | 2篇 |
1940年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
112.
Xiao-Chen Chen Hao Sun Chang-Jun Zhang Ying Zhang Ke-Qin Lin Liang Yu Lei Shi Yu-Fen Tao Xiao-Qin Huang Jia-You Chu Zhao-Qing Yang 《遗传学报》2013,40(10):543-548
The ataxin-2 (ATXN2) gene is located on human chromo-some 12q24.1. In normal individuals, the coding region in exon 1 of this gene has fewer than 31 CAG repeats (Yu et al., 2005: Laffita-Mesa et al., 2012). However, an abnormal expansion of CAG trinucleotide repeats results in the aggre-gation of polyglutamine (polyQ), which causes spinocer-ebellar ataxia type 2 (SCA2) (Pulst et al., 1996). The expanded alleles have more than 32 repeats in the affected individuals, and generally there is an inverse correlation between CAG repeat length and age of onset (Pulst et al., 1996). SCA2 is an autosomal dominant inheritance neurodegenerative disease, whose major clinical feature is progressive cerebellar ataxia. Atrophies of the brainstem and frontal lobe have been frequently detected by magnetic resonance imaging (MRI) (Yamamoto-Watanabe et al., 2010). This disease has the strong effect on sensory and motor control. 相似文献
113.
Xiaopei Shen Shan Li Lin Zhang Hongdong Li Guini Hong XianXiao Zhou Tingting Zheng Wenjing Zhang Chunxiang Hao Tongwei Shi Chunyang Liu Zheng Guo 《PloS one》2013,8(4)
Background
Cancer cells typically exhibit large-scale aberrant methylation of gene promoters. Some of the genes with promoter methylation alterations play “driver” roles in tumorigenesis, whereas others are only “passengers”.Results
Based on the assumption that promoter methylation alteration of a driver gene may lead to expression alternation of a set of genes associated with cancer pathways, we developed a computational framework for integrating promoter methylation and gene expression data to identify driver methylation aberrations of cancer. Applying this approach to breast cancer data, we identified many novel cancer driver genes and found that some of the identified driver genes were subtype-specific for basal-like, luminal-A and HER2+ subtypes of breast cancer.Conclusion
The proposed framework proved effective in identifying cancer driver genes from genome-wide gene methylation and expression data of cancer. These results may provide new molecular targets for potential targeted and selective epigenetic therapy. 相似文献114.
Tryptase, the most abundant mast cell (MC) granule protein, plays an important role in atherosclerosis plaque development. To test the hypothesis that tryptase participates directly in atherosclerosis plaque haemorrhage, the gene sequence and siRNA for tryptase were cloned into a lentivirus carrier and atherosclerosis plaque haemorrhage models in ApoE-/- mice were constructed. After a cuffing-cervical artery operation, the mice were randomly divided into 6 groups. Hematoxylin and eosin(HE) staining showed that the cervical artery plaque area was much larger in the tryptase overexpression group compared to the other groups, and there was greater artery stenosis. The artery stenosis from the cuff-side in all groups was more than 90%, except the siRNA group. Tryptase promotes plaque haemorrhage distinctively because 50% of the mice in the tryptase overexpression group had plaque haemorrhage, while only 10% in the siRNA group did. The immunohistochemistry of the cervical artery plaque showed that plasminogen activator inhibitor-1 (PAI-1) expression was the lowest while tissue plasminogen activator (tPA), CD31, CD34 and VEGF was the highest in the tryptase overexpression groups. This observation was completely contrary to what was observed in the siRNA group. Tryptase promoted bEnd.3 cell growth, migration and capillary-like tube formation, which suggests that tryptase can promote microvessel angiogenesis. PAI-1 expression was inhibited, while tPA expression was increased by tryptase in bEnd.3 cells. Our in vivo and in vitro studies suggest that trypase can promote atherosclerotic plaque haemorrhage by promoting angiogenesis and regulating the balance of PAI-1 and tPA. Thus, regulating tryptase expression in MCs may provide a potential target for atherosclerosis treatment. 相似文献
115.
116.
117.
118.
119.
120.
Anaplastic lymphoma kinase (ALK) plays a crucial role in multiple malignant cancers. It is known as a well-established target for the treatment of ALK-dependent cancers. Even though substantial efforts have been made to develop ALK inhibitors, only crizotinib, ceritinib, and alectinib had been approved by the U.S. Food and Drug Administration for patients with ALK-positive non-small cell lung cancer (NSCLC). The secondary mutations with drug-resistance bring up difficulties to develop effective drugs for ALK-positive cancers. To give a comprehensive understanding of molecular mechanism underlying inhibitor response to ALK tyrosine kinase mutations, we established an accurate assessment for the extensive profile of drug against ALK mutations by means of computational approaches. The molecular mechanics-generalized Born surface area (MM-GBSA) method based on molecular dynamics (MD) simulation was carried out to calculate relative binding free energies for receptor-drug systems. In addition, the structure-based virtual screening was utilized to screen effective inhibitors targeting wild-type ALK and the gatekeeper mutation L1196M from 3180 approved drugs. Finally, the mechanism of drug resistance was discussed, several novel potential wild-type and L1196M mutant ALK inhibitors were successfully identified. 相似文献